Bone Therapeutics

#Bone Therapeutics #Finance

Bone Therapeutics hedges bets on cell therapy platform  

Cell therapy company Bone Therapeutics has announced it is shifting its R&D activities towards its most advanced clinical asset, the allogenic cell therapy platform, ALLOB.   The platform    ALLOB is an off-the-shelf allogenic cell therapy platform consisting of human allogeneic bone-forming cells derived from… Read More

#News